Bupropion Hydrobromide Tablet, Extended Release
Product Images NDC 68682-580

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrobromide (NDC 68682-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

174mg Label (174mg)

This is an text from a medication label for Bupropion Hydrobromide extended-release tablets. Each tablet contains 174 mg of the active ingredient. The warning on the label advises not to use this medication with other substances. The manufacturer of the tablets is Bausch Health Companies Inc. It is a prescription-only medication and must be dispensed as per federal law. The label also mentions USP Controlled Room conditions. The text includes information such as the manufacturer's address and that it is a product of Italy.*

FDA Label Image

348 mg Label (348mg)

This text provides information about an extended-release tablet containing 348 mg of bupropion hydrobromide. The usual dosage instructions are to refer to the prescribing information. It is recommended to store the tablets at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The product is distributed by Oceanside Pharmaceuticals and manufactured by Bausch Health Companies Inc. This medication is to be taken once daily in accordance with Federal Law, and it mentions the requirement of dispensing bupropion hydrobromide extended-release tablets with the Medication Guide attached.*

FDA Label Image

522mg Label (522mg)

This is a description for extended-release bupropion hydrobromide tablets. The warning on the label cautions against using the tablets with other medications containing bupropion. These tablets are to be taken once daily and each contains 522 mg of bupropion hydrobromide. The usual dosage should be determined by a healthcare provider. The tablets should be stored at 25°C with excursions permitted within a range of 15° to 30°C. The product is distributed by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, and manufactured by Bausch Health Companies Inc. in Canada.*

FDA Label Image

Chemical Structure (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.